KharazniEDossusLRohrmannS. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study. Heart2010; Epub ahead of print. December 2010.
3.
HughesGRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Brit Med J1983; 287: 1088–1089.
BranchDWSilverRMPorterTF. Obstetric antiphospholipid syndrome:current uncertainties should guide the way. Lupus2010; 19: 446–452.
7.
MeroniPLTedescoFLocatM. Antiphospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view. Lupus2010; 19: 453–456.
8.
HughesGRVKhamashtaMA. Sero-negative antiphospholipid syndrome. Ann Rheum Dis2003; 62: 2127–2127.
9.
HughesGRV. Antiphospholipid syndrome, migraine and stroke. Lupus2010; 19: 555–556.
10.
AshersonRAKhamashtaMABaguleyE. Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Quart J Med1989; 73: 1103–1115.
11.
GrecoTPConti-KellyAMGrecoTJr. Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome. Am J Clin Pathol2009; 132: 613–620.
12.
UrbanusRTSeigerinkBRoestM. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the ratio study: a case control study. Lancet Neurol2009; 8: 998–1005.